Y, L., X, H., J, Z., & S, Z. (2021). Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma. Dove Medical Press.
Style de citation Chicago (17e éd.)Y, Luo, Huang X, Zhan J, et Zhang S. Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)Y, Luo, et al. Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.